CT
CytomX Therapeutics
CTMX·NASDAQS San Francisco CAFounded 2008180 employees
Micro CapbiotechPublicOncology
Platform: Probody ADC
Market Cap
$0.2B
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (CTMX)
Loading CTMX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CTM-2131 | CTM-2131 | Phase 3 | 3 | IL-17A | FL | ||
| Adagralemzoparlimab | CTM-6226 | Phase 2/3 | 2 | PD-L1 | FL |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)